Conversely, during MS relapses, IFN-β stimulation induces the enrichment of PD-1+CD8 T cells in the cerebrospinal fluid, which contributes to self-immune regulation and is correlated with a positive response to subsequent treatment [59]. This evidence concerns the gene CD8A and myeloid sarcoma.